Atlas Trials

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT00301990 · UNKNOWN

Trial details

NCT number
NCT00301990
Sponsor
Jonsson Comprehensive Cancer Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer
Start date
2005-09-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.